Holen Sie sich die Stockscreener-App
0.40
1.27%
0.005
Handel nachbörslich:
.40
Schlusskurs vom Vortag:
$0.395
Offen:
$0.395
24-Stunden-Volumen:
652.79K
Relative Volume:
0.08
Marktkapitalisierung:
$8.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.0692
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
-3.10%
1M Leistung:
+3.90%
6M Leistung:
-49.24%
1J Leistung:
-58.95%
1-Tages-Spanne:
$0.3914
$0.4156
1-Wochen-Bereich:
$0.3487
$0.4156
52-Wochen-Spanne:
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Firmenname
Adial Pharmaceuticals Inc
Sektor
Branche
Telefon
434-422-9800
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Vergleichen Sie ADIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.40 | 8.09M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2018-10-30 | Eingeleitet | Maxim Group | Buy |
| 2018-10-11 | Eingeleitet | Dawson James | Buy |
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Adial Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adial Pharmaceuticals files to register resale of 6.7M shares from warrant conversions - MSN
Adial Pharmaceuticals Completes FDA Meeting, Advances AD04 into Phase 3 Clinical Development - AInvest
Adial Pharmaceuticals' Regulatory and Strategic Momentum with AD04: A Catalyst for Partnership and Growth in a High-Potential Market - AInvest
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting | AD - GuruFocus
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug - Investing.com
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting - GlobeNewswire
Adial Pharmaceuticals Completes Successful FDA Meeting for Phase 3 Trial of AD04 for Alcohol Use Disorder Treatment. - AInvest
Adial's Alcohol Addiction Treatment Gets FDA Green Light for Pivotal Phase 3 Trial, Partnership Talks Heat Up - Stock Titan
Candlestick Reversal Detected on Adial Pharmaceuticals Inc.’s ChartProfit Focused Trade Alerts - beatles.ru
Sentiment Tools Show Shift in Trader Mood on Adial Pharmaceuticals Inc.Weekly Stock Opportunity Radar Scanner Activated - beatles.ru
Technical Bounce Expected in Adial Pharmaceuticals Inc. Next WeekSector Based Breakout Stock Forecast Issued - metal.it
Published on: 2025-08-04 18:30:20 - beatles.ru
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
What is the risk reward ratio of investing in Adial Pharmaceuticals Inc. stockBuild wealth with reliable stock picks - Jammu Links News
How many analysts rate Adial Pharmaceuticals Inc. as a “Buy”Rapid growth opportunities - Jammu Links News
What drives Adial Pharmaceuticals Inc. stock priceTriple returns potential - Jammu Links News
How does Adial Pharmaceuticals Inc. generate profit in a changing economyBoost your returns with professional guidance - Jammu Links News
What analysts say about Adial Pharmaceuticals Inc. stockHigh-profit capital plays - Jammu Links News
How strong is Adial Pharmaceuticals Inc. company’s balance sheetFree Stock Selection - Jammu Links News
Adial Pharmaceuticals Approves Share Increase Amid Ongoing Financial Struggles - AInvest
What is Adial Pharmaceuticals Inc. company’s growth strategyGet timely alerts on market opportunities - Jammu Links News
What is the dividend policy of Adial Pharmaceuticals Inc. stockGet exclusive market analysis for investors - Jammu Links News
What are Adial Pharmaceuticals Inc. company’s key revenue driversMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Adial Pharmaceuticals Inc. stock higher in 2025Dynamic growth stocks - Jammu Links News
Published on: 2025-08-03 01:06:20 - jammulinksnews.com
Is Adial Pharmaceuticals Inc. a growth stock or a value stockBreakout Stocks Tracker With High Returns - jammulinksnews.com
Adial Pharmaceuticals shareholders approve share increases and board proposals By Investing.com - Investing.com Australia
Adial Pharmaceuticals Enters New Sales Agreement - TipRanks
Adial Pharmaceuticals shareholders approve share increases and board proposals - Investing.com
Adial Pharmaceuticals Approves Share Increase at Annual Meeting - TipRanks
Adial Pharmaceuticals Inc. Plunges 10.55% Amid Investor Concerns - AInvest
SHEN files 8-K, releases Q2 2025 earnings press release | ADIL SEC FilingForm 424B5 - Stock Titan
What are the technical indicators suggesting about Adial Pharmaceuticals Inc.Chart Pattern Planner For Beginners - Jammu Links News
Adial Pharmaceuticals Inc. Plunges 16.67% in Pre-Market Trading - AInvest
Adial Pharmaceuticals Inc. Shows Risk Reward Favoring UpsideBuy Signal Based on Chart Analysis Confirmed - metal.it
Alcohol Use Disorder Pipeline 2025: Therapies Under - openPR.com
Should You Forget Palantir and Buy 2 Artificial Intelligence (AI) Stocks Instead? - The Globe and Mail
Published on: 2025-07-29 13:05:24 - metal.it
P&G Announces Fourth Quarter and Fiscal Year 2025 Results - The Globe and Mail
Adial Pharmaceuticals Soars 14.6% on Bullish Sentiment - AInvest
Adial Pharmaceuticals Inc. (ADIL) Soars 12.06% on Investor Optimism - AInvest
Ichimoku Cloud Indicates Uncertainty Around Adial Pharmaceuticals Inc.Entry Alert Based on Volume Spikes Detected - metal.it
Adial Pharmaceuticals Skyrockets 28.09% – What’s Fueling This Volcanic Surge? - AInvest
What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakthrough stock performance - jammulinksnews.com
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):